» Articles » PMID: 38753769

Vaccine Priming of Rare HIV Broadly Neutralizing Antibody Precursors in Nonhuman Primates

Abstract

Germline-targeting immunogens hold promise for initiating the induction of broadly neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen recognition is typically dominated by heavy chain complementarity determining region 3 (HCDR3) interactions, and vaccine priming of HCDR3-dominant bnAbs by germline-targeting immunogens has not been demonstrated in humans or outbred animals. In this work, immunization with N332-GT5, an HIV envelope trimer designed to target precursors of the HCDR3-dominant bnAb BG18, primed bnAb-precursor B cells in eight of eight rhesus macaques to substantial frequencies and with diverse lineages in germinal center and memory B cells. We confirmed bnAb-mimicking, HCDR3-dominant, trimer-binding interactions with cryo-electron microscopy. Our results demonstrate proof of principle for HCDR3-dominant bnAb-precursor priming in outbred animals and suggest that N332-GT5 holds promise for the induction of similar responses in humans.

Citing Articles

Vaccination with mRNA-encoded membrane-bound HIV Envelope trimer induces neutralizing antibodies in animal models.

Ramezani-Rad P, Cottrell C, Marina-Zarate E, Liguori A, Landais E, Torres J bioRxiv. 2025; .

PMID: 39896562 PMC: 11785158. DOI: 10.1101/2025.01.24.634423.


Broadly inhibitory antibodies to severe malaria virulence proteins.

Reyes R, Raghavan S, Hurlburt N, Introini V, Bol S, Kana I Nature. 2024; 636(8041):182-189.

PMID: 39567685 DOI: 10.1038/s41586-024-08220-3.


HIV Vaccine Development at a Crossroads: New B and T Cell Approaches.

Govindan R, Stephenson K Vaccines (Basel). 2024; 12(9).

PMID: 39340073 PMC: 11435826. DOI: 10.3390/vaccines12091043.


Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response.

Bhagchandani S, Yang L, Lam J, Maiorino L, Ben-Akiva E, Rodrigues K Sci Immunol. 2024; 9(99):eadl3755.

PMID: 39303017 PMC: 11492009. DOI: 10.1126/sciimmunol.adl3755.


mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models.

Wang X, Cottrell C, Hu X, Ray R, Bottermann M, Villavicencio P Sci Immunol. 2024; 9(95):eadn0622.

PMID: 38753808 PMC: 11488661. DOI: 10.1126/sciimmunol.adn0622.


References
1.
Park S, Venable J, Xu T, Yates 3rd J . A quantitative analysis software tool for mass spectrometry-based proteomics. Nat Methods. 2008; 5(4):319-22. PMC: 3509211. DOI: 10.1038/nmeth.1195. View

2.
Shipley M, Prasad V, Doepker L, Dingens A, Ralph D, Harkins E . Functional development of a V3/glycan-specific broadly neutralizing antibody isolated from a case of HIV superinfection. Elife. 2021; 10. PMC: 8376252. DOI: 10.7554/eLife.68110. View

3.
Steichen J, Lin Y, Havenar-Daughton C, Pecetta S, Ozorowski G, Willis J . A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science. 2019; 366(6470). PMC: 7092357. DOI: 10.1126/science.aax4380. View

4.
Vazquez Bernat N, Corcoran M, Nowak I, Kaduk M, Dopico X, Narang S . Rhesus and cynomolgus macaque immunoglobulin heavy-chain genotyping yields comprehensive databases of germline VDJ alleles. Immunity. 2021; 54(2):355-366.e4. DOI: 10.1016/j.immuni.2020.12.018. View

5.
Zhao F, Joyce C, Burns A, Nogal B, Cottrell C, Ramos A . Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques. Cell Rep. 2020; 32(10):108122. PMC: 7487785. DOI: 10.1016/j.celrep.2020.108122. View